i10 Productivity
Rankings
Eli Lilly and Company Scientists i10 Productivity Rankings 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
Computational Mechanics
Biomechancis
Mechanobiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Computational Chemistry/Biophysics
Molecular Dynamics
Enhanced Sampling
Surfactants/Polymers
Proteins/Biomembranes
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Cell biology
Neuroscience
Neurodegenerative disorders
Gene therapy
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
translational activities
cell cycle
skin models
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
4
0.800
Machine Learning
Cheminformatics
RL
Computer Vision
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Drug Discovery
Generative AI
Reaction informatics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
RNA Tx
Surfaceome
RNA regulation
Bioinformatics
Muscle and CNS disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Organic Chemistry
Peptide Chemistry
Small Molecules
Oligonucleotides
Medicinal Compounds
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Organic chemistry
Cheminformatics
Reaction Informatics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Synthetic Organic Chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
statistics
drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Amyotrophic lateral sclerosis
Neuropathic pain
In vivo electrophysiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
3
0.750
molecular biology
diabetes
muscle
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
3
0.750
Neurodegenerative disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
2
0.500
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
2
0.500
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
1
0.250
Analytical Chemistry
LCMS
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
0
0.000
high performance computing
scientific workflows
Cloud computing
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
antibody discovery
antibody engineering
protein design
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Gene Editing
Neurodegenerative Diseases
Rare Diseases
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Obesity
Endocrinology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Biochemistry
Cancer Biology
Bacterial Toxins
Actin
Oncolytic viruses CRISPR
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Medical Information
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
2
0.667
Vivek Dharmangadan Sree|Vivek D Sree, Vivek Sree
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Pradyumn Sharma
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Computational Chemistry/Biophysics
Molecular Dynamics
Enhanced Sampling
Surfactants/Polymers
Proteins/Biomembranes
Ramya Lakshminarayan
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Cell biology
Neuroscience
Neurodegenerative disorders
Gene therapy
Zapatero-Solana,E
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
translational activities
cell cycle
skin models
Josh Poorbaugh
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
5
4
0.800
Sarkhan Badirli
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Machine Learning
Cheminformatics
RL
Computer Vision
Chuqin Li
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Pushkar Ghanekar
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Pooja Gangras
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
RNA Tx
Surfaceome
RNA regulation
Bioinformatics
Muscle and CNS disease
Ankur Jalan
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Organic Chemistry
Peptide Chemistry
Small Molecules
Oligonucleotides
Medicinal Compounds
Nathan M Lui
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Organic chemistry
Cheminformatics
Reaction Informatics
Juntian Zhang
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Robert D Kinley
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Su-Wei Kuo
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
3
0.750
Amyotrophic lateral sclerosis
Neuropathic pain
In vivo electrophysiology
Brandy Snider
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
3
0.750
molecular biology
diabetes
muscle
oncology
Griffin Fitzgerald
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
2
0.500
Thomas Zachary Gunter
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
2
0.500
Joseph Turpin
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
1
0.250
James Koers
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
0
0.000
Feng Li
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
high performance computing
scientific workflows
Cloud computing
Xiaoxiao Zhang
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Zikun Wang
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Krishna Karthik Chivukula
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Vedud Purde
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Biochemistry
Cancer Biology
Bacterial Toxins
Actin
Oncolytic viruses CRISPR
Angeles Flores
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
3
2
0.667